| Product Code: ETC334168 | Publication Date: Aug 2022 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The mumps vaccine market in Indonesia is estimated to be worth around USD 5.7 million, and is expected to reach a value of USD 8.9 million, growing at a CAGR of 10.4% over the forecast period. This growth can be attributed to an increase in government investments for immunization programs focused on improving access to quality health care services across the country. In addition, increasing awareness about the preventive healthcare benefits associated with vaccination has further boosted demand for mumps vaccines from both public and private sectors in recent years.
The Indonesia mumps vaccine market is poised for substantial growth in the coming years. Several key drivers are fueling this expansion. Firstly, increasing awareness about the importance of vaccination in preventing diseases has led to higher demand for mumps vaccines. The Indonesian government`s efforts to improve healthcare infrastructure and promote immunization further contribute to this trend. Additionally, rising incidences of mumps outbreaks in various regions of Indonesia have underscored the urgency for vaccination.
The Indonesia Mumps Vaccine market is poised for growth due to increasing awareness about immunization and government efforts to expand vaccination programs. However, several challenges need to be addressed. The accessibility and affordability of vaccines in remote areas remain a concern, requiring improved distribution infrastructure. Additionally, vaccine hesitancy fueled by misinformation poses a threat to achieving widespread coverage. Overcoming these challenges requires collaborative efforts between health authorities, healthcare providers, and community influencers to ensure the population reaps the benefits of mumps vaccination.
The COVID-19 pandemic has significantly impacted various industries in Indonesia, including the vaccine, musical instrument, essential oils, natural extracts, cosmetics, and raw materials sectors. These markets have experienced shifts in demand, supply chain disruptions, and changes in consumer behavior due to the ongoing pandemic.
The Indonesia mumps vaccine market is expected to experience steady growth due to increasing awareness about vaccination and healthcare. Key players in this market include PT Bio Farma (Persero), which is a state-owned company involved in the production and distribution of vaccines.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Indonesia Mumps Vaccine Market Overview |
3.1 Indonesia Country Macro Economic Indicators |
3.2 Indonesia Mumps Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Indonesia Mumps Vaccine Market - Industry Life Cycle |
3.4 Indonesia Mumps Vaccine Market - Porter's Five Forces |
3.5 Indonesia Mumps Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.6 Indonesia Mumps Vaccine Market Revenues & Volume Share, By Distribution channel, 2021 & 2031F |
4 Indonesia Mumps Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination in preventing mumps |
4.2.2 Government initiatives to improve immunization coverage in Indonesia |
4.2.3 Rise in mumps outbreaks driving demand for vaccines |
4.3 Market Restraints |
4.3.1 Limited access to healthcare services in rural areas impacting vaccine distribution |
4.3.2 Low awareness about mumps vaccination among certain population segments |
5 Indonesia Mumps Vaccine Market Trends |
6 Indonesia Mumps Vaccine Market, By Types |
6.1 Indonesia Mumps Vaccine Market, By Age Group |
6.1.1 Overview and Analysis |
6.1.2 Indonesia Mumps Vaccine Market Revenues & Volume, By Age Group, 2021-2031F |
6.1.3 Indonesia Mumps Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.1.4 Indonesia Mumps Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.2 Indonesia Mumps Vaccine Market, By Distribution channel |
6.2.1 Overview and Analysis |
6.2.2 Indonesia Mumps Vaccine Market Revenues & Volume, By Hospitals Pharmacies, 2021-2031F |
6.2.3 Indonesia Mumps Vaccine Market Revenues & Volume, By Drug Stores, 2021-2031F |
6.2.4 Indonesia Mumps Vaccine Market Revenues & Volume, By Retail Pharmacies, 2021-2031F |
7 Indonesia Mumps Vaccine Market Import-Export Trade Statistics |
7.1 Indonesia Mumps Vaccine Market Export to Major Countries |
7.2 Indonesia Mumps Vaccine Market Imports from Major Countries |
8 Indonesia Mumps Vaccine Market Key Performance Indicators |
8.1 Immunization coverage rate for mumps vaccine |
8.2 Number of mumps cases reported annually |
8.3 Percentage increase in vaccination rates among children under the age of 5 |
8.4 Number of healthcare facilities offering mumps vaccination services |
8.5 Level of public awareness campaigns on mumps vaccination |
9 Indonesia Mumps Vaccine Market - Opportunity Assessment |
9.1 Indonesia Mumps Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.2 Indonesia Mumps Vaccine Market Opportunity Assessment, By Distribution channel, 2021 & 2031F |
10 Indonesia Mumps Vaccine Market - Competitive Landscape |
10.1 Indonesia Mumps Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Indonesia Mumps Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here